Literature DB >> 19122534

Rating scales in bipolar disorder.

Angelo Picardi1.   

Abstract

PURPOSE OF REVIEW: Bipolar disorder is a complex clinical entity that presents with pleomorphic signs and symptoms varying from depression to hypomania, full-blown mania, mixed states, and psychosis. Therefore, the assessment of patients with bipolar disorder poses a difficult challenge to clinicians, who may find themselves puzzled when having to choose among the many instruments available. This paper aims at briefly reviewing these instruments. RECENT
FINDINGS: Observer-rated and self-completed instruments for the assessment of depressive, manic, and psychotic symptoms in patients with bipolar disorder are described with emphasis on topics of increasing interest in recent times, such as the assessment of bipolar depression, self-rating of manic symptoms, daily mood monitoring, screening, and early recognition of bipolar disorder.
SUMMARY: The use of standardized assessment instruments has many advantages as it enables clinicians to be more systematic and it allows greater precision, increased sensitivity to change, and opportunity to identify longitudinal patterns. Knowledge of available options for the assessment of patients with bipolar disorder may help clinicians and researchers to choose the most appropriate instruments for their specific needs.

Entities:  

Mesh:

Year:  2009        PMID: 19122534     DOI: 10.1097/YCO.0b013e328315a4d2

Source DB:  PubMed          Journal:  Curr Opin Psychiatry        ISSN: 0951-7367            Impact factor:   4.741


  5 in total

1.  Systematic Review of Symptom Assessment Measures for Use in Measurement-Based Care of Bipolar Disorders.

Authors:  Joseph M Cerimele; Simon B Goldberg; Christopher J Miller; Stephen W Gabrielson; John C Fortney
Journal:  Psychiatr Serv       Date:  2019-02-05       Impact factor: 3.084

2.  An item response theory evaluation of the young mania rating scale and the montgomery-asberg depression rating scale in the systematic treatment enhancement program for bipolar disorder (STEP-BD).

Authors:  James J Prisciandaro; Bryan K Tolliver
Journal:  J Affect Disord       Date:  2016-07-13       Impact factor: 4.839

3.  Role of omega-3 fatty acids in the treatment of depressive disorders: a comprehensive meta-analysis of randomized clinical trials.

Authors:  Giuseppe Grosso; Andrzej Pajak; Stefano Marventano; Sabrina Castellano; Fabio Galvano; Claudio Bucolo; Filippo Drago; Filippo Caraci
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

4.  Defining cognitive and functional profiles in schizophrenia and affective disorders.

Authors:  Yu-Chi Huang; Yu Lee; Chun-Yi Lee; Pao-Yen Lin; Chi-Fa Hung; Sheng-Yu Lee; Liang-Jen Wang
Journal:  BMC Psychiatry       Date:  2020-01-31       Impact factor: 3.630

5.  Saving time and money: a validation of the self ratings on the prospective NIMH Life-Chart Method (NIMH-LCM).

Authors:  Christoph Born; Benedikt L Amann; Heinz Grunze; Robert M Post; Lars Schärer
Journal:  BMC Psychiatry       Date:  2014-05-07       Impact factor: 3.630

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.